Antitrust Issues in Generic Substitution: How Big Pharma Blocks Cheaper Drugs
Big Pharma uses legal tricks like product hopping and REMS abuse to block generic drugs from entering the market. These tactics undermine state substitution laws, delay savings, and cost consumers billions annually.